Alyeska Investment Group, L.P. Nkarta, Inc. Transaction History
Alyeska Investment Group, L.P.
- $25 Billion
- Q4 2024
A detailed history of Alyeska Investment Group, L.P. transactions in Nkarta, Inc. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 1,334,696 shares of NKTX stock, worth $2.34 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,334,696
Previous 1,084,696
23.05%
Holding current value
$2.34 Million
Previous $4.9 Million
32.21%
% of portfolio
0.01%
Previous 0.03%
Shares
5 transactions
Others Institutions Holding NKTX
# of Institutions
120Shares Held
61.3MCall Options Held
17.6KPut Options Held
1.11M-
Ra Capital Management, L.P. Boston, MA10.8MShares$18.9 Million0.44% of portfolio
-
Black Rock Inc. New York, NY4.06MShares$7.1 Million0.0% of portfolio
-
Samsara Bio Capital, LLC Palo Alto, CA3.77MShares$6.59 Million2.88% of portfolio
-
Nea Management Company, LLC Timonium, MD3.57MShares$6.25 Million0.63% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.56MShares$6.24 Million0.0% of portfolio
About Nkarta, Inc.
- Ticker NKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,656,800
- Market Cap $85.1M
- Description
- Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...